Endocrine Regulation – Chapter 25 Study Notes
Learning Objectives
- Compare endocrine structure & function with nervous structure & function
- Classify hormones in multiple, non-exclusive ways
- Structural/chemical class
- Functional/physiologic class
- Contrast mechanisms of action of steroid vs. non-steroid hormones
- Explain endocrine reflexes plus receptor up- & down-regulation
- Detail eicosanoids (prostaglandins, thromboxanes, leukotrienes):
- Chemical nature (20-C fatty acid w/ 5-C ring)
- Classification & mechanism of action
- Describe mechanisms and causes of hormone hyper- & hyposecretion
Neuroendocrine System: Organization & General Functions
- Endocrine + nervous systems form a single integrated “neuroendocrine system”
- Shared general functions
- Communication
- Integration of body processes
- Control / regulation
- Endocrine pathway
- Secreting (ductless) glandular epithelial cells → hormone molecules enter blood → circulate to virtually every tissue → bind only to cells bearing specific receptors (“target cells”)
- Response time: usually slow, but duration: long-lasting
- Nervous pathway
- Neuron → neurotransmitter into synaptic cleft → postsynaptic cell
- Response time: fast, duration: brief
Major Endocrine Glands (illustrated on classic diagram)
- Hypothalamus
- Pineal gland
- Pituitary (anterior & posterior lobes)
- Thyroid
- Parathyroids (posterior thyroid surface)
- Thymus
- Pancreatic islets
- Adrenal cortex & medulla
- Gonads
- Testes (male)
- Ovaries (female)
Functional Classes of Hormones
- Tropic hormones – regulate secretion of another endocrine gland
- Sex hormones – reproductive target tissues/functions
- Anabolic hormones – stimulate anabolism (cell/tissue building)
- Overlaps occur; e.g., \text{GH} is anabolic & tropic
Structural / Chemical Classification of Hormones
- Steroid hormones (lipid soluble, derived from cholesterol)
- Cortisol, Aldosterone, Estrogens, Progesterone, Testosterone
- Non-steroid hormones (primarily amino-acid based)
- Proteins: GH, PRL, PTH, CT, ACTH, Insulin, Glucagon
- Glycoproteins: FSH, LH, TSH, hCG
- Peptides: ADH, OT, MSH, SS, TRH, GnRH, ANH
- Amino-acid derivatives (Amines/iodinated AA): NE, Epi, Melatonin, T4, T3
Steroid Hormones
Basic Properties
- Synthesized from cholesterol → lipid soluble → diffuse through plasma membranes
- Circulate largely bound to plasma proteins; only free fraction is active
- Receptors typically intracellular (cytosolic or nuclear)
Representative Ring Structure
- Steroid nucleus = 3 six-carbon rings + 1 five-carbon ring
- Functional groups (e.g., \ce{OH},\; C=O) determine mineralocorticoid vs. glucocorticoid vs. sex steroid activity
Synthetic Pathway (mitochondria & smooth ER)
- Cholesterol → Pregnenolone → multiple branch points →
- Mineralocorticoids: 11\text{-Deoxycorticosterone} \to Corticosterone \to Aldosterone
- Glucocorticoids: 17\alpha\text{-Hydroxyprogesterone} \to 11\text{-Deoxycortisol} \to Cortisol
- Androgens/Estrogens: Dehydroepiandrosterone \to Androstenedione \to Testosterone \to Estradiol
Non-steroid Hormones
Proteins & Peptides
- Built from chains of amino acids; may contain disulfide bridges (e.g., insulin’s A & B chains linked via S–S)
- Peptides shorter than ~50 aa (e.g., Oxytocin = 9 aa)
Glycoproteins
- Protein backbone + carbohydrate side chains; α-subunit shared, β-subunit confers specificity (e.g., hCG vs. TSH)
Amino-acid derivatives
- Tyrosine/tryptophan modifications; thyroid hormones iodinated (organification) producing T4 and T3
Principles of Hormone Action
- Receptor-mediated “lock-and-key” specificity
- Magnitude of response ∝ [hormone] × [receptor] × receptor affinity
- Multiple hormones may act on a single target:
- Synergism – combined > sum of individual (e.g., Epi + Glucagon → ↑blood glucose)
- Permissiveness – one hormone allows full action of another (e.g., T_3 permits Epi-induced lipolysis)
- Antagonism – opposite effects (e.g., Insulin vs. Glucagon)
Mechanisms of Action
Steroid (Mobile-Receptor / Nuclear-Receptor Model)
- Free steroid diffuses across plasma membrane
- Binds cytosolic receptor → hormone–receptor complex
- Complex translocates to nucleus, binds hormone-response element (HRE) on DNA
- Initiates or represses transcription → mRNA → protein synthesis
- Responses are slow onset (hours) but long duration
- Magnitude determined by free [hormone]; no “amplification cascade” inside cell
Non-steroid (Fixed-Membrane / Second-Messenger Models)
- Hormone cannot cross membrane; receptor is integral protein, often a G-protein–coupled receptor (GPCR)
- Binding activates intracellular signals → enzyme cascades → rapid amplification
Calcium–Calmodulin Pathway (illustrated with Oxytocin example)
- Hormone (first messenger) binds GPCR → activates G-protein + PIP_2 system
- Voltage- or ligand-gated Ca^{++} channels open; extracellular Ca^{++} floods cytosol (down gradient)
- Ca^{++} binds calmodulin → conformational change → Ca^{++}-calmodulin complex (second messenger)
- Complex allosterically activates or inhibits target enzymes → physiological response
- Other pathways (not pictured but implied): cAMP, cGMP, IP_3 / DAG
Regulation of Hormone Secretion
Endocrine Reflexes (Negative Feedback Loops)
- Example: Parathyroid hormone (PTH) control of blood Ca^{++}
- Sensor-integrator: parathyroid chief cells
- Controlled variable: [Ca^{++}]_{blood}
- Effector: Osteoclast activation → bone resorption → ↑Ca^{++}
- Correction signal stops once variable returns to set-point
Receptor Density Modulation
- Up-regulation: prolonged low [hormone] → ↑number of receptors → ↑sensitivity
- Down-regulation: chronic high [hormone] → receptor internalization/degradation → ↓sensitivity
Eicosanoids
- Unique lipid mediators; do not meet classical endocrine definition (local action)
- Derived from 20-carbon fatty acid (arachidonic acid) w/ 5-carbon ring
Tissue Hormones
- Synthesized & act within same tissue; diffusion distance: paracrine/autocrine
Prostaglandins (PGs)
- Multiple structural series: PGA, PGE, PGF, etc.
- Extremely diverse effects: vascular tone, uterine contraction, inflammation, platelet aggregation, gastric mucosal protection
- Also include thromboxanes, leukotrienes (not detailed in slides but included under “eicosanoids” umbrella)
Endocrine Disorders
Hypersecretion
- Hyperthyroidism (e.g., Graves’ disease)
- Hyperpituitarism (e.g., GH-secreting adenoma → acromegaly)
- Autoimmunity stimulating receptor (e.g., TSH-R antibodies)
Hyposecretion
- Gland destruction, enzyme defects, dietary deficiency, receptor insensitivity
- Iatrogenic: negative feedback suppression after exogenous anabolic steroid abuse
Connections & Clinical / Ethical Implications
- Understanding receptor regulation is essential for drug therapy (e.g., β-blocker tolerance, insulin resistance)
- Eicosanoid pathways are targets of NSAIDs (aspirin inhibits COX → ↓PG synthesis) → benefits & GI side-effects
- Steroid abuse highlights hyposecretion rebound; ethical concern in sports
- Interplay of endocrine & nervous systems important in stress (HPA axis), lactation (neuroendocrine reflex), reproduction, etc.
Quick Reference Equations & Numbers
- Steroid nucleus: C{17}H{28}O_{2} core + side-chains (varies)
- Eicosanoid definition: 20-carbon chain + 5-carbon ring
- Receptor occupancy equation (simplified): \theta = \frac{[H]}{[H]+K_d} (θ = fraction of occupied receptors)